Who We Are
At Azura Ophthalmics, we are utilizing our deep understanding of ocular surface diseases and drug development to deliver a new therapeutic class of Ophthalmic Keratolytics to treat underserved ophthalmic conditions.
Our goal is to change the paradigm for the treatment of ophthalmic conditions by delivering First-in-Class Ophthalmic Keratolytics.
Harnessing the power of keratolytics for lid margin and ocular surface diseases.
Treating the core pathophysiology to improve signs, symptoms, and burden of ophthalmic conditions.